6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19198975 | COMBINATION THERAPY USING A CD47-SIRP alpha BLOCKING AGENT AND AZACITIDINE | HIBSHMAN, SARAH GRACE | 1693 | Final Rejection | May 05, 2025 |
| 18406841 | Method for Treating Diseases Using SMARCA2/4 Degraders | JACKSON, SHAWQUIA | 1626 | Non-Final OA | Jan 08, 2024 |
| 18564384 | CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Nov 27, 2023 |
| 18257962 | COCRYSTAL OF A CDK INHIBITOR | LEE, CHIHYI NMN | 1628 | Non-Final OA | Jun 16, 2023 |
| 18044329 | HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS | MOORE, SUSANNA | 1624 | Final Rejection | Mar 07, 2023 |
| 17045916 | METHOD OF MODULATING TIGIT AND PD-1 SIGNALLING PATHWAYS USING 1,2,4-OXADIAZOLE COMPOUNDS | VALENROD, YEVGENY | 1628 | Final Rejection | Oct 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial